What does this research mean for the field?

CST4 promotes epithelial-mesenchymal transition (EMT) and tumor progression in ovarian cancer via the Wnt/β-catenin signaling pathway. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The research aims to investigate CST4's role in enhancing epithelial-mesenchymal transition (EMT) and tumor advancement in ovarian cancer.

March 2, 2026Discover Oncology1 citationsOpen Access

CST4 promotes EMT and tumor progression in ovarian cancer via Wnt/β-catenin signaling

JSJunjun Shao WGWei GaoFirst Affiliated Hospital of Bengbu Medical College YLYuzhi LiFirst Affiliated Hospital of Bengbu Medical College

Puntos clave

The research aims to investigate CST4's role in enhancing epithelial-mesenchymal transition (EMT) and tumor advancement in ovarian cancer.
Investigated CST4 expression in ovarian cancer cells
Analyzed the effects of CST4 on EMT markers
Assessed the involvement of Wnt/β-catenin signaling pathway
CST4 expression correlates with increased EMT markers
CST4 promotes tumor cell invasion and growth
Wnt/β-catenin signaling pathway mediates the effects of CST4

Resumen

CST4 is a novel oncogenic regulator in OC that promotes EMT and tumor aggressiveness via the Wnt/β-catenin signaling pathway. It may serve as an independent prognostic biomarker and potential therapeutic target for OC.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo